Berbice Capital Management LLC Invests $59,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Berbice Capital Management LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, Holdings Channel.com reports. The fund bought 100 shares of the biotechnology company’s stock, valued at approximately $59,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board increased its stake in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc increased its stake in Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC acquired a new position in Axon Enterprise in the third quarter valued at $221,000. Sequoia Financial Advisors LLC increased its stake in Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after purchasing an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in Axon Enterprise in the third quarter valued at $814,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $613.38 on Friday. The stock has a fifty day moving average price of $617.43 and a two-hundred day moving average price of $467.42. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $46.77 billion, a P/E ratio of 158.50, a PEG ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have commented on AXON shares. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Finally, The Goldman Sachs Group upped their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.